Prognostic significance of proliferative activity, DNA-ploidy, p53 and Ki-ras point mutations in colorectal liver metastases

Cell Proliferation

Volumn 31, Issue 3-4, 1998, Pages 139-153

  Russo, A ^a,b   Migliavacca, M ^a   Bazan, V ^a   Maturi, N ^a   Morello, V ^a   Dardanoni, G ^a   Modica, G ^a   Bazan, P ^a   Albanese, I ^a   La Farina, M ^a   Tomasino, R M ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PARAFFIN; PROTEIN P53;

ADULT; AGED; ARTICLE; CELL CYCLE S PHASE; CELL PROLIFERATION; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MALE; ONCOGENE RAS; PLOIDY; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; STATISTICAL ANALYSIS; SURVIVAL;

EID: 17944384553     PISSN: 09607722     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2184.1998.tb01192.x     Document Type: Article

References (48)

1. ALBANASE I, RINAUDO CR, ALBERTI M et al. (1997) ras and myc analysis in primary and metastatic colorectal carcinomas: specific ras mutations are associated with Dukes' D stage and mucinous histotype. Int. J. Oncol. 10, 293.
2. BAUER KD, BAGWELL CB, GIARETTI W et al. (1993) Consensus review of the clinical utility of DNA flow cytometry in colorectal cancer. Cytometry 14, 486.
3. BERGERS E, MONTIRONI R, VAN DIEST PJ, PRETE E, BAAK JPA. (1996) Interlaboratory reproducility of semiautomated cell cycle analysis of flow cytometric DNA-histograms obtained from fresh material of 1295 breast cancer cases. Hum. Pathol. 27, 553.
4. BERGERS E, VAN DIEST PJ, BAAK JPA. (1995) Reproducibility of semiautomated cell cycle analysis of flow cytometric DNA-histograms of fresh breast cancer material. Anal. Cell. Pathol. 8, 1.
5. BOS JL. (1989) ras oncogene in human cancer: a review. Cancer Res. 49, 4682.
6. BRUNO, S, DARZYNKIEWICZ Z. (1992) Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells. Cell Prof. 25, 31.
7. CADY B, STONE M, MCDERMOTT W et al. (1992) Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch. Surg. 127, 561.
8. COX DR. (1972) Regression models and life tables. J. R. Stat. Soc. 34, 187.
9. CRIPPS KJ, PURDIE CA, CARDER PJ et al. (1994) A study of stabilisation of p53 protein versus point mutation in colorectal carcinoma. Oncogene 9, 2739.
10. DALY JM, KEMENY NE. (1997) Metastatic cancer to the liver. In: DeVita Jr VT, Hellman S, Rosemberg SA, eds. Cancer: Principles and Practice of Oncology. Philadelphia: Lippincott-Raven Publishers, 2551.
11. DEAN PN, JETT JH. (1974) Mathematical analysis of DNA distributions derived from flow microfluorometry. J. Cell Biol. 60, 523.
12. ELLIS PA, MAKRIS A, BURTON SA et al. (1996) Comparison of MIB-1 proliferation index with S-phase fraction in human breast carcinomas. Br. J. Cancer 73, 640.
13. GERDES J, LEMKE H, BAISC H, WACKER HH, SCHWAB U, STEIN H. (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by monoclonal antibody ki-67. J. Immunol. 133, 1710.
14. GILLILAND R, WILLIAMSON KE, WILSON RH, ANDERSON NH, HAMILTON PW. (1996) Colorectal cell kinetics. Br. J. Surg. 83, 739.
15. GOH HS, SMITH DR. (1995) p53 point mutations and survival in colorectal cancer patients. Cancer Res. 55, 5217.
16. HAMELIN R, LAURENT-PUIG P, OLSCHWANG S et al. (1994) Association of p53 mutations with short survival in colorectal cancer. Gastroenterology 106, 42.
17. HONGYO T, BUZARD GS, CALVERT RJ, WEGHORST CM (1993) 'Cold SSCP': a simple, rapid and non-radioactive method for optimized single-strand conformation polymorphism analyses. Nucl. Acids Res. 21, 3637.
18. KAPLAN EL, MEIER P. (1958) Non parametric estimation from incomplete observations. J. Am. Stat. Assoc. 53, 457.
19. KASTRINAKIS WV, RAMCHURREN N, RIEGER KM et al. (1995) Increased incidence of p53 mutations is associated with hepatic metastasis in colorectal neoplastic progression. Oncogene 11, 647.
20. KEY G, BECKER MHG, DUCHROW M, SCHLUTER C, GERDES J (1992) New ki-67 equivalent murine monoclonal antibodies (MIB 1-3) prepared against recombinant parts of the ki-67 antigen. Anal. Cell. Pathol. 4, 181.
21. KOKAL WA, DUDA RB, AZUMI N et al. (1986) Tumor DNA content and metastatic colorectal carcinoma. Arch. Surg. 121, 1434.
22. LA FARINA M, ALBERTI M, RUSSO A et al. (1993) Optimization of RNA and DNA purification procedures from human colorectal carcinomas. Anticancer Res. 13, 1485.
23. LIND DS, PARKER GA, HORSLEY SS et al. (1992) Formal hepatic resection of colorectal liver metastases. Ploidy and prognosis. Ann. Surg. 215, 677.
24. LOPEZ F, BELLOC F, LACOMBE F et al. (1991) Modalities of synthesis of ki67 antigen during the stimulation of lymphocytes. Cytometry 12, 42.
25. MEYER JS, COPLIN MD. (1988) Thymidine labeling index, flow cytometric S-phase measurement, and DNA index in human tumors. Am. J. Clin. Pathol. 89, 586.
26. NIGRO JM, BAKER SJ, PREISINGER AC et al. (1989) Mutations in the p53 gene occur in diverse human tumour types. Nature 342, 705.
27. PETO R, PIKE MC, ARMITAGE P et al. (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patients. II Analysis and examples. Br. J. Cancer 35, 1.
28. PICH A, PONTI R, VALENTE G et al. (1994) MIB-1, ki-67, PCNA scores DNA flow cytometry in intermediate grade malignant lymphomas. J. Clin. Pathol. 4, 18.
29. PINDER SE, WENCYK P, SIBBERING DM et al. (1995) Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival. Br. J. Cancer 71, 146.
30. PRICOLO V, FINKELSTEIN SD, WU TT et al. (1996) Prognostic value of TP53 and k-ras-2 mutational analysis in stage III carcinoma of the colonb. Am. J. Surg. 171, 41.
31. RAVINOVITCH PS. (1990) Numerical compensation for the effects of cell clumping on DNA histograms. Cytometry 4 (Suppl.), 27.
32. RUSSO A, BAZAN V, MORELLO V et al. (1994) Vimentin expression, Proliferating Cell Nuclear Antigen and flow cytometric factors. Prognostic role in breast. Anal. Quant. Cytol. Histol. 16, 365.
33. RUSSO A, BAZAN V, PLAJA S, LEONARDI P, BAZAN P. (1991) Patterns of DNA-ploidy in operable colorectal carcinoma: A prospective study of 100 cases. J. Surg. Oncol. 48, 4.
34. SANTISTEBAN MS, BRUGEL G. (1994) Image analysis of in situ cell cycle related changes of PCNA and Ki-67 proliferating antigen expression. Cell Prolif. 27, 435.
35. SCHLUTER C, DUCHROW M, WOHLENBERG C et al. (1993) The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J. Cell Biol. 123, 513.
36. SILVESTRINI R. (1994) Cell kinetics: prognostic and therapeutic implications in human tumours. Cell Prolif. 27, 579.
37. SILVESTRINI R, COSTA A, GENNARI L et al. (1990) Cell kinetics of hepatic metastases as a prognostic marker in patients with advanced colorectal carcinoma. HPB Surg. 2, 135.
38. SILVESTRINI R, THE SICCAB GROUP FOR QUALITY CONTROL OF CELL KINETIC DETERMINATIONS. (1994) Quality control for evaluation of the S-phase fraction by flow cytometry: a multicentric study. Cytometry-Comms Clin. Cytometry 18, 11.
39. SMITH DR, ELNATAN J, GOH HS. (1996) Point mutation of the c-ki-ras proto-oncogene and the p53 tumour suppressor gene in distal colonic adenocarcinomas. Int. J. Oncol. 8, 1165.
40. TOMASINO RM, DANIELE E, BAZAN V et al. (1995) Prognostic significance of cell kinetics in laryngeal squamous cell carcinoma: clinicopathological associations. Cancer Res. 55, 6103.
41. TRANBERG K, BENGMARK S. (1994) Metastatic tumour of the liver. In: Blumgart LH, ed. Surgery of the Liver and Biliary Tract. Edinburgh: Churchill Livingstone, 1385.
42. TSUSHIMA K, NAGORNEY DM, RAINWATER LM et al. (1987) Prognostic significance of nuclear deoxyribonucleic acid poloidy patterns in resected hepatic metastases from colorectal carcinoma. Surgery 102, 635.
43. VAN DIERENDONCK JH, VAN KEIJZER R, VAN DE VELDE CJH, CORNELISSE CJ. (1989) Nuclear distribution of the ki-67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells. Cancer Res. 49, 2999.
44. VIELH P, CHEVILLARD S, MOSSERI V, DONATINI B, MAGDELENAT H. (1990) ki-67 index and S-phase fraction in human breast carcinomas. Am. J. Clin. Pathol. 94, 681.
45. YAMAGUCHI A, ISHIDA T, TAKEGAWA S, NISHIMURA G, KANNO M. (1990) Flow-cytometric analysis of colorectal cancer with hepatic metastases and its relationship to metastatic characteristics and prognosis. Oncology 47, 478.
46. YAO J, GOH HS, SMITH DR. (1996) p53 mutations in primary colorectal adenocarcinomas and liver metastases. Br. J. Surg. 83, 1245.
47. YAP EPH, MCGEE JOD. (1992) Nonisotopic SSCP detection in PCR products by ethidium bromide staining. Trends Genet. 8, 49.
48. YOUSSEF EM, MATSUDA T, TAKADA N et al. (1995) Prognostic significance of the MIB-1 proliferation index for the patients with squamous cell carcinoma of the esophagus. Cancer 76, 358.